Template:Cilostazol: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8...") |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 26: | Line 26: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Cilostazol clinical pharmacology|Clinical Pharmacology]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Cilostazol clinical pharmacology|Clinical Pharmacology]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Cilostazol | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Cilostazol toxicitiy|Toxicity]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Cilostazol clinical studies|Clinical Studies]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Cilostazol clinical studies|Clinical Studies]] | ||